Perakizumab (RG4934) is a humanized IgG1kappa monoclonal antibody against IL-17A (Interleukin Related). Perakizumab can be uesd for the research of autoimmune diseases, such as psoriatic arthritis[1].
Molecular Weight:
(145.8 kDa)
Purity:
99.79
CAS Number:
[89957-37-9]
Target:
Interleukin Related
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted